# Jin Wang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jin-wang-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,313 |
| Field | Protein Degradation and Inhibitors |
| h-index | 66 |
| i10-index | 279 |
| Last Known Institution | Hebei Medical University |
| OpenAlex ID | https://openalex.org/A5082431907 |
| ORCID iD | https://orcid.org/0000-0003-3625-7919 |
| Works | 793 |

## Researcher papers

- [Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial](https://scholariq.org/papers/afatinib-beyond-progression-in-patients-with-non-small-cell-lung-cancer/)

## Researcher topics

- [Chemical Reactions and Mechanisms](https://scholariq.org/topics/chemical-reactions-and-mechanisms/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways-2/)

## Researcher university

- [Hebei Medical University](https://scholariq.org/institutions/hebei-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.